REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 140 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,183 | -54.8% | 54,627 | -50.2% | 0.06% | -61.4% |
| Q4 2022 | $2,615 | -99.9% | 109,790 | -14.3% | 0.14% | -5.2% |
| Q3 2022 | $2,526,000 | +453.9% | 128,110 | +447.9% | 0.15% | +350.0% |
| Q2 2022 | $456,000 | +8.6% | 23,380 | +53.1% | 0.03% | -39.3% |
| Q3 2021 | $420,000 | +23.9% | 15,272 | +42.9% | 0.06% | -50.9% |
| Q2 2021 | $339,000 | -31.9% | 10,690 | -1.5% | 0.11% | -28.3% |
| Q1 2021 | $498,000 | +23.6% | 10,850 | +6.6% | 0.16% | +38.3% |
| Q4 2020 | $403,000 | – | 10,176 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |